ACCESSION: MSBNK-SMB_Measured-HSA032P0173002
RECORD_TITLE: Characterized; C00050425; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 16
COMMENT: RAW_SPEC {'RA5-pos_965': {'bp': 3313.0, 'sum': 12563.0}, 'RA4-pos_918': {'bp': 3121.0, 'sum': 11934.0}, 'RA5-pos_978': {'bp': 2984.0, 'sum': 13016.0}, 'RA14-pos_506': {'bp': 2685.0, 'sum': 10515.0}, 'RA4-pos_907': {'bp': 2124.0, 'sum': 8268.0}, 'RA14-pos_517': {'bp': 1915.0, 'sum': 8956.0}, 'RA14-pos_824': {'bp': 1830.0, 'sum': 6647.0}, 'RA12-pos_955': {'bp': 728.0, 'sum': 2666.0}, 'HC19-pos_911': {'bp': 721.0, 'sum': 2517.0}, 'RA12-pos_983': {'bp': 689.0, 'sum': 3254.0}, 'QC2-pos_909': {'bp': 626.0, 'sum': 3300.0}, 'HC7-pos_890': {'bp': 441.0, 'sum': 1961.0}, 'HC10-pos_937': {'bp': 437.0, 'sum': 1597.0}, 'HC12-pos_939': {'bp': 390.0, 'sum': 1840.0}, 'RA9-pos_884': {'bp': 385.0, 'sum': 1466.0}, 'QC4-pos_920': {'bp': 318.0, 'sum': 1563.0}}
COMMENT: RETENTION_TIME_STDEV 0.217
COMMENT: PRECURSOR_M/Z_RAW 173.138994
COMMENT: PRECURSOR_M/Z_STDEV 0.000540
COMMENT: PRECURSOR_IN_MS1 mz 173.139619; int 333.247; delta(ppm) 8.606104
COMMENT: PROPOSED_CHARGE_STATE +1; mz 174.141845; int 26.174; cor 0.908
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+NH4; M+H; mz 156.112362; int 18.936; cor 0.971
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.790; C7H16N4O; [M+H]+; delta(ppm) -0.790090
COMMENT: PROPOSED_MF SevenGoldenRules 0.864; C7H13N3O; [M+NH4]+; delta(ppm) -0.863927
COMMENT: PROPOSED_MF MS-FINDER 3.848; C7H16N4O; [M+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF MS-FINDER 3.256; C7H13N3O; [M+NH4]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF MS-FINDER 2.108; C7H24S2; [M+H]+; delta(ppm) 1.916391
COMMENT: PROPOSED_MF SIRIUS5_Sirius 45.755; C7H16N4O; [M+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF SIRIUS5_Sirius 45.755; C7H13N3O; [M+H3N+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF SIRIUS5_Sirius 26.639; C9H18NO2; [M+H]+; delta(ppm) -8.543657
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H13N3O; [M+H3N+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H16N4O; [M+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF SIRIUS6_Sirius 73.093; C7H13N3O; [M+H3N+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF SIRIUS6_Sirius 73.093; C7H16N4O; [M+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF SIRIUS6_Sirius 43.002; C9H15O2; [M+H3N+H]+; delta(ppm) -8.543657
COMMENT: PROPOSED_MF SIRIUS6_Sirius 43.002; C9H18NO2; [M+H]+; delta(ppm) -8.543657
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.484; C5H11N6; [M+H3N+H]+; delta(ppm) 6.965931
COMMENT: PROPOSED_MF SIRIUS6_Sirius 33.484; C5H14N7; [M+H]+; delta(ppm) 6.965931
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H13N3O; [M+H3N+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H16N4O; [M+H]+; delta(ppm) -0.788923
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.140; JMACEDIUUMWDIC-UHFFFAOYSA-N; [M+H]+; CC(=O)NCCCCNC(N)=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.395; BGCBKTVIXRMRQY-UHFFFAOYSA-N; [M+H]+; CC(=O)OC1CCC[N+](C1)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.265; DYEAYLYVJSBXII-SVGMAFHSNA-N; [M+H]+; CCOC(=O)[C@@H]1CCC[N+]1(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.212; UZFMOKQJFYMBGY-UHFFFAOYSA-N; [M+H]+; CC1(C)CC(O)CC(C)(C)N1[O]
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; USFMMZYROHDWPJ-UHFFFAOYSA-N; [M+H]+; CC(=C)C(=O)OCC[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.496; JMACEDIUUMWDIC-UHFFFAOYSA-N; [M+H]+; C00050425
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JMACEDIUUMWDIC-UHFFFAOYSA-N; [M+H]+; C00050425
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; OCKWQPYGAAJALM-UHFFFAOYSA-N; [M+H]+; N'-hydroxy-2-(4-methylpiperazin-1-yl)ethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.889; KZDDDHJBINUIKQ-UHFFFAOYSA-N; [M+NH4]+; (cyclohexylideneamino)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.492; QTMFWQYTTCWLLT-UHFFFAOYSA-N; [M+NH4]+; 1-(3-aminopyrazol-1-yl)-2-methylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.439; WJLKJRCGDXKJDQ-UHFFFAOYSA-N; [M+NH4]+; 1-(4-aminopyrazol-1-yl)-2-methylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.192; XLZONOPLKJMTSW-UHFFFAOYSA-N; [M+NH4]+; 1,3,8-triazaspiro[4.5]decan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.631; VMVMLAPJMPSWAT-UHFFFAOYSA-N; [M+NH4]+; 1-(2-methoxyethyl)-3-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.434; APQXTYBDGHVRLL-UHFFFAOYSA-N; [M+NH4]+; 4-(azetidin-3-yl)piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.393; UUUPNGVYOIXAAC-UHFFFAOYSA-N; [M+NH4]+; 2,3,4,6,7,8,9,9a-octahydropyrazino[1,2-a]pyrazin-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.339; KETGYXFSSXEWJZ-UHFFFAOYSA-N; [M+NH4]+; (1-tert-butyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.331; AKXFFMCJCUWAEW-UHFFFAOYSA-N; [M+NH4]+; 5-(2-methoxyethyl)-2-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.328; VPWBADFKGVCXAK-UHFFFAOYSA-N; [M+NH4]+; 2-pentan-3-yl-2H-1,3,4-oxadiazol-5-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.310; BEYHIMKJBKQLIY-UHFFFAOYSA-N; [M+NH4]+; 1-(2-methoxyethyl)-4-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.306; PNYUPJKMGKFHDO-UHFFFAOYSA-N; [M+NH4]+; 2-[(1-methylpyrazol-4-yl)methylamino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.280; DBTHZKBZEPHVSD-UHFFFAOYSA-N; [M+NH4]+; 2-amino-3-(1-methylpyrazol-4-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.278; JGAMQVOQQRMPCV-UHFFFAOYSA-N; [M+NH4]+; 2-(1-ethyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.269; SBDVCNXINPNTRT-UHFFFAOYSA-N; [M+NH4]+; 2-amino-1-(1-ethylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.268; OWDXVKSJDZVIRF-UHFFFAOYSA-N; [M+NH4]+; 1,3,9-triazaspiro[4.5]decan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.238; GBGPFEUIUBKMBG-UHFFFAOYSA-N; [M+NH4]+; 3,4,5,6-tetrahydro-2H-azepin-7-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.228; FNPLZEGCLDXUNX-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-1,5,6,7,8,8a-hexahydroimidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.226; MOHHSDPEILNAAZ-UHFFFAOYSA-N; [M+NH4]+; 1-methyl-3-propan-2-yloxypyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.225; FPHXPEVYGTUARP-UHFFFAOYSA-N; [M+NH4]+; 1-methyl-3a,4,5,6,7,7a-hexahydro-3H-imidazo[4,5-c]pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.220; YSSFGHDOTMVSKA-UHFFFAOYSA-N; [M+NH4]+; 1-pyrrolidin-3-ylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.212; KPSCRVKNEQXWFI-UHFFFAOYSA-N; [M+NH4]+; (5-methoxy-1,3-dimethylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.199; QOKQCHFUXVEDOX-WDSKDSINSA-N; [M+NH4]+; (4aS,8aR)-3,4,4a,5,6,7,8,8a-octahydro-1H-pyrido[3,4-d]pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.180; FDMCHLIWKHORRD-NTSWFWBYSA-N; [M+NH4]+; (4aS,8aR)-3,4,4a,5,6,7,8,8a-octahydro-1H-pyrido[4,3-d]pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.177; YVAJCRXLDZAPGJ-UHFFFAOYSA-N; [M+NH4]+; 2-[4-(aminomethyl)-3-methylpyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.157; UJOIYNRKVLSATP-UHFFFAOYSA-N; [M+NH4]+; 4-(4,5-dihydro-1H-imidazol-2-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.134; YHEHJNDTUBEPMU-UHFFFAOYSA-N; [M+NH4]+; (5-methyl-4-propyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; VUYZHZVVPAQDRU-UHFFFAOYSA-N; [M+NH4]+; 2-(3-methyl-1,2,4-oxadiazol-5-yl)butan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; OUZMXGKGLFQIBO-UHFFFAOYSA-N; [M+NH4]+; 3-methoxy-1-propan-2-ylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.106; GVXSNDGQVGYILF-UHFFFAOYSA-N; [M+NH4]+; 2-methoxy-1-(2-methylpyrazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; VPSNFEHZWICSMN-UHFFFAOYSA-N; [M+NH4]+; (3-tert-butyl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; TYVNHUYYFGJCRL-UHFFFAOYSA-N; [M+NH4]+; 1-amino-2-(1-methylpyrazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; PDGHHTQEFCPEGH-UHFFFAOYSA-N; [M+NH4]+; 3-[(5-methyl-1H-pyrazol-3-yl)oxy]propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; AXTVMGZNJFYTBK-UHFFFAOYSA-N; [M+NH4]+; 2-methoxy-1-(1-methylpyrazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; HWFKKNPYEMKTKF-UHFFFAOYSA-N; [M+NH4]+; 1-(azetidin-3-yl)-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.007; FXYRTTMATPBDLI-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-1-(3-methyl-1,2,4-oxadiazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; WYKZLECSHGWAQL-UHFFFAOYSA-N; [M+NH4]+; 2-(5-propan-2-yl-1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; LENWSPLYWGKMCZ-UHFFFAOYSA-N; [M+NH4]+; 2-(5-ethyl-1,2,4-oxadiazol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; XLYZRTVNKRYLPM-UHFFFAOYSA-N; [M+NH4]+; [2-[(dimethylamino)methyl]-1,3-oxazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.915; NLIJXQFEQWQNAD-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; YKCAYAQNJASPLT-UHFFFAOYSA-N; [M+NH4]+; 1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.725; DEMYOKSOUVVNGZ-UHFFFAOYSA-N; [M+NH4]+; (5-tert-butyl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -38.649; JMACEDIUUMWDIC; [M+H]+; Acetylagmatine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.026; GCCQNSQKSSOQIR; [M+H]+; 2-(4-amino-5-oxohexyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.899; HVKAESUVPQRMBV; [M+H3N+H]+; 2-amino-3-butyl-4H-imidazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.140; GBGPFEUIUBKMBG; [M+H3N+H]+; 2-(Carbamidoimino)hexahydroazepine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.196; NRFSJPLMHMLGTM; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.810; KDXQCFMEMPJHOB; [M+H]+; 2-[(4S)-4-amino-5-hydroxyhex-5-enyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.912; FNXGWGAOSHYTSX; [M+H]+; 4-Methylpiperazine-1-acetohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.447; KZDDDHJBINUIKQ; [M+H3N+H]+; Cyclohexanal semicarbazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.694; JMACEDIUUMWDIC; [M+H]+; Acetylagmatine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.161; HVKAESUVPQRMBV; [M+H3N+H]+; 2-amino-3-butyl-4H-imidazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -67.764; JMACEDIUUMWDIC; [M+H]+; Acetylagmatine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.844; BQWVUIAESBARIM; [M+H]+; 1-(N'-butylcarbamimidoyl)-3-methylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.591; DXJNSCMACTZNLR; [M+H3N+H]+; 4-amino-4-ethenylimino-N-methylbutanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.696; GCCQNSQKSSOQIR; [M+H]+; (4-Azaniumyl-5-oxohexyl)-(diaminomethylidene)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -148.027; ODQUULZAWWZDTI; [M+H3N+H]+; 2-[[amino(cyclopropyl)methylidene]amino]-N-methylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -152.911; PZVYRUMPYOTMEB; [M+H3N+H]+; N-[1-amino-2-(methylamino)ethylidene]cyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -153.642; NOUYAOUUFQXIAM; [M+H3N+H]+; 4-[[(E)-2,3-diaminoprop-2-enylidene]amino]butanal
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -155.168; HKZMMEDDDPNMJC; [M+H3N+H]+; 3-[[Amino(cyclopropyl)methylidene]amino]propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -157.007; AEYGHJLIIWAESR; [M+H3N+H]+; 2-(1-aminoethylideneamino)-N-cyclopropylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -157.168; FHWKVWOPRADAIX; [M+H3N+H]+; N-(3,3-diaminoprop-2-enyl)-2-methylprop-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -158.783; QDMZAMKPAIGXEU; [M+H3N+H]+; 2-[[Amino(cyclopropyl)methylidene]amino]propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.433; PPKPIYXYPVHNMF; [M+H3N+H]+; 2-(2-Methylpropylamino)-1,4-dihydroimidazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.994; NYEUFBBZMBXFIP; [M+H3N+H]+; 3,3-diamino-2-methyl-N-prop-2-enylprop-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.567; OCKWQPYGAAJALM; [M+H]+; (1Z)-N'-Hydroxy-2-(4-methyl-1-piperazinyl)ethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.288; FNXGWGAOSHYTSX; [M+H]+; 1-Piperazineacetic acid, 4-methyl-, hydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.372; JMACEDIUUMWDIC; [M+H]+; Acetylagmatine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.242; DXJNSCMACTZNLR; [M+H3N+H]+; 4-amino-4-ethenylimino-N-methylbutanamide
COMMENT: CONFIDENCE Level 3: Tentative candidate, C00050425, JMACEDIUUMWDIC-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1);
CH$NAME: C00050425
CH$NAME: N-[4-(diaminomethylideneamino)butyl]acetamide
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C7H16N4O
CH$EXACT_MASS: 172.132411
CH$SMILES: CC(=O)NCCCCN=C(N)N
CH$IUPAC: InChI=1S/C7H16N4O/c1-6(12)10-4-2-3-5-11-7(8)9/h2-5H2,1H3,(H,10,12)(H4,8,9,11)
CH$LINK: CHEBI CHEBI:2412
CH$LINK: INCHIKEY JMACEDIUUMWDIC-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:439661
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.468
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 173.139551
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0229-9400000000-2c336c88237fb224d69b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  30.0337793 91.2349 30.034077 18.0796 46.65 0.8027 14 f{C1H4N1}/-1.54ppm,p-C6H13N3O1
  43.0174637 92.4327 43.017774 16.9699 51.54 0.7756 14 f{C2H3O1}/-8.77ppm,p-C5H14N4
  43.0287264 44.7933 43.029036 16.4541 24.27 0.7757 13 f{C1H3N2}/-8.09ppm,p-C6H14N2O1
  55.0539051 124.5903 55.054163 17.0560 43.11 0.8112 16 f{C4H7}/-5.84ppm,p-C3H10N4O1
  55.9340252 73.2183 55.934277 23.8674 57.68 0.2095 14 ?
  60.0443381 155.1182 60.044557 11.1584 55.99 0.9116 16 f{C2H6N1O1}/-0.87ppm,p-C5H11N3
  60.0548734 69.7002 60.055092 28.6571 40.51 0.8254 14 f{C3H8O1}/-34.85ppm,p-C4H9N4
  72.0441769 572.1684 72.044334 6.9818 198.74 0.9382 16 f{C3H6N1O1}/-2.96ppm,p-C4H11N3
  72.0806887 999.0000 72.080846 4.8140 105.57 0.9471 16 f{C4H10N1}/-1.21ppm,p-C3H7N3O1
  90.9025224 87.5599 90.902760 12.1119 67.46 -0.3083 14 ?
  97.0766056 112.4908 97.076873 13.7108 76.06 0.9604 14 f{C5H9N2}/5.98ppm,p-C2H8N2O1
  113.1072049 234.8318 113.107557 8.0013 70.18 0.9110 16 f{C6H13N2}/-1.06ppm,p-C1H4N2O1
  114.0913337 992.3443 114.091692 6.2844 113.61 1.0000 16 f{C6H12N1O1}/-0.06ppm,p-C1H5N3
  115.0864544 41.8279 115.086818 16.3008 12.06 0.7904 12 f{C5H11N2O1}/-1.17ppm,p-C2H6N2
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  30.033779 91.23 91
  43.017464 92.43 92
  43.028726 44.79 44
  55.053905 124.59 124
  55.934025 73.22 73
  60.044338 155.12 155
  60.054873 69.70 69
  72.044177 572.17 572
  72.080689 999.00 999
  90.902522 87.56 87
  97.076606 112.49 112
  113.107205 234.83 234
  114.091334 992.34 992
  115.086454 41.83 41
//
